Featured News
AIM Blog
Recognizing AIM’s August Advocate of the Month: Vinitia Strong-McDonald
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted by Alzheimer’s and all other dementia remain top-of-mind in Congres...
All News
Press Release
House Unanimously Approves Bipartisan Legislation to Strengthen Dementia Public Health Infrastructure
Washington, D.C., September 17, 2024 — Today the U.S. House of Representatives unanimously passed the bipartisan BOLD Infrastructure for Alzheimer’s...
Press Release
Senate Passes Bipartisan Bills to Renew Nation’s Commitment to Addressing Alzheimer’s
NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act Washington, D.C., July 30, 2024 — Today the Senate unanimously passed...
Press Release
Alzheimer’s Association Statement on European Medicines Agency Negative Opinion on Leqembi for the Treatment of Alzheimer’s Disease
CHICAGO, July 26, 2024 — The Alzheimer’s Association is disappointed by today’s decision by the European Medicines Agency (EMA) to...
Press Release
Alzheimer’s Association Welcomes U.S. FDA Approval of Kisunla (Donanemab)
CHICAGO, July 2, 2024 — The Alzheimer’s Association celebrates today’s U.S. Food and Drug Administration (FDA) action to approve Kisunla™...
Press Release
Alzheimer’s Association Welcomes FDA Advisory Committee Unanimous Vote of Efficacy of Donanemab for the Treatment of Early Alzheimer’s Disease
CHICAGO, June 10, 2024 — The Alzheimer’s Association welcomes today’s U.S. Food and Drug Administration (FDA) advisory committee’s unanimous finding...
Press Release
Senate HELP Committee Advances BOLD Legislation to Renew Nation’s Commitment to Dementia Public Health Infrastructure
Washington, D.C., May 23, 2024 — Today the Senate Committee on Health, Education, Labor and Pensions (HELP) overwhelmingly passed the...